跳至主要内容
临床试验/NCT02449694
NCT02449694已完成不适用

Single-arm Prospective Trial to Evaluate The Safety and Performance of The Portable Organ Care System (OCS™) Liver For Preserving and Assessing Donor Livers for Transplantation

TransMedics2 个研究点 分布在 1 个国家目标入组 25 人开始时间: 2016年5月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
TransMedics
入组人数
25
试验地点
2
主要终点
Number of donor livers preserved by OCS in a near physiologic state.

研究概览

简要总结

A prospective, single-center controlled trial to evaluate the safety and performance of the portable Organ Care System (OCS) Liver for preservation and assessment of donor livers for transplantation.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Registered male or female primary Liver transplant candidate
  • Age ≥18 years old
  • Signed: written informed consent

排除标准

  • Acute, fulminant liver failure;
  • Prior solid organ or bone marrow transplant;
  • Chronic use of hemodialysis or diagnosis of chronic renal failure, defined as chronic serum creatinine of >3 mg/dl (>265 mmol/L) for >2 weeks and/or requiring hemodialysis;
  • Multi-organ transplant;
  • Ventilator dependent;
  • Dependent on > 1 IV inotrope to maintain hemodynamics;
  • Malignancy excluding HCC;
  • Infection.

研究组 & 干预措施

OCS Liver

Experimental

OCS Liver will be used to preserve the donor liver

干预措施: OCS Liver (Device)

结局指标

主要结局

Number of donor livers preserved by OCS in a near physiologic state.

时间窗: Within 1 day of organ retrieval

Number of events directly related to the use of the OCS Liver that led to the donor liver being deemed not clinically acceptable and, as a result, not transplanted

时间窗: Within 1 day of organ retrieval

次要结局

  • Number of donor livers monitored for perfusate temperatures, SvO2, hematocrit, Hepatic Artery flow rates, Portal Vein flow rate, Hepatic Artery pressure, Portal vein pressure, and bile production during preservation.(Within 1 day of organ retrieval)
  • Number of donor livers maintained in a metabolically active and functioning state during preservation.(Within 1 day of organ retrieval)
  • Frequency of liver graft-related serious adverse events(30 days after transplantation)

研究者

发起方
TransMedics
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验